Jennifer Jarrett
At-Large
At Burke's, Jen serves on the Advancement and Governance Committees.
Jennifer Jarrett is an experienced executive in the healthcare and technology industries. She currently serves as Chief Operating Officer of Arcus Biosciences, a biotech company focused on oncology drug development. Previously, she served as Vice President of Corporate Development and Capital Markets of Uber and, prior to that, Chief Financial Officer of Medivation until its acquisition by Pfizer. Jen also spent 20 years in investment banking, most recently at Citigroup where she ran their west coast life sciences investment banking practice. Jen currently serves on the boards of Arcus, Syndax Pharma, Zura Bio and LifeMine Therapeutics, and previously served on the boards of Arena Pharma, Audentes Therapeutics and Radius Health. She also serves on the board of SMART.
Jen holds a B.A. in economics from Dartmouth College and an M.B.A. from Stanford Graduate School of Business.
Burke's mission is to educate, encourage and empower girls. Our school combines academic excellence with an appreciation for childhood so that students thrive as learners, develop a strong sense of self, contribute to community, and fulfill their potential, now and throughout life.
Burke's admits students of any race, color, national and ethnic origin to all the rights, privileges, programs, and activities generally accorded or made available to students at the school. It does not discriminate on the basis of race, color, national and ethnic origin in administration of its educational policies, admissions policies, scholarship and loan programs, and athletic and other school-administered programs.